ABSENCE OF ANTIOXIDANT EFFECTS OF NIFEDIPINE AND DILTIAZEM ON MYOCARDIAL MEMBRANE LIPID-PEROXIDATION IN CONTRAST WITH THOSE OF NISOLDIPINE AND PROPRANOLOL

被引:21
作者
SUGAWARA, H [1 ]
TOBISE, K [1 ]
ONODERA, S [1 ]
机构
[1] ASAHIKAWA MED COLL, DEPT INTERNAL MED 1, ASAHIKAWA 078, JAPAN
关键词
NISOLDIPINE; NIFEDIPINE; MYOCARDIAL MEMBRANE LIPID PEROXIDATION; ANTIPEROXIDATION; CALCIUM ANTAGONISTS; TBA TEST;
D O I
10.1016/0006-2952(94)90489-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Both the production of active oxygen species and cellular damage due to concurrent lipid peroxidation are believed to be important factors in the pathogenesis of cardiovascular diseases and the ageing process. Since cardiovascular drugs are often administered over a long term, it might be advantageous if they reduced lipid peroxidation. There have been conflicting reports concerning the antiperoxidant effect of nifedipine. Therefore, we investigated whether nifedipine could inhibit lipid peroxidation in a nonenzymatic active oxygen-generating system, utilizing rat crude myocardial membranes, and compared its effect with those of propranolol, nisoldipine, and diltiazem. Nifedipine and diltiazem had no inhibitory effects on the lipid peroxidation of myocardial membranes. In contrast, nisoldipine and propranolol had a concentration-dependent antiperoxidant effect, with IC50 values of 28.2 and 50.1 mu M, respectively. In addition, nisoldipine appeared to possess dual antiperoxidant mechanisms, involving both preventive and chain-breaking properties.
引用
收藏
页码:887 / 892
页数:6
相关论文
共 18 条
[1]   LIPID PEROXIDE FORMATION IN RAT BRAIN [J].
BISHAYEE, S ;
BALASUBRAMANIAN, AS .
JOURNAL OF NEUROCHEMISTRY, 1971, 18 (06) :909-+
[2]   THE MEASUREMENT AND MECHANISM OF LIPID-PEROXIDATION IN BIOLOGICAL-SYSTEMS [J].
GUTTERIDGE, JMC ;
HALLIWELL, B .
TRENDS IN BIOCHEMICAL SCIENCES, 1990, 15 (04) :129-135
[3]   STRUCTURAL-ANALYSIS OF DRUG MOLECULES IN BIOLOGICAL-MEMBRANES [J].
HERBETTE, LG ;
CHESTER, DW ;
RHODES, DG .
BIOPHYSICAL JOURNAL, 1986, 49 (01) :91-94
[4]   ANTIPEROXIDANT EFFECTS OF DIHYDROPYRIDINE CALCIUM-ANTAGONISTS [J].
JANERO, DR ;
BURGHARDT, B .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (23) :4344-4348
[5]   PROTECTION OF CARDIAC MEMBRANE PHOSPHOLIPID AGAINST OXIDATIVE INJURY BY CALCIUM-ANTAGONISTS [J].
JANERO, DR ;
BURGHARDT, B ;
LOPEZ, R .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (21) :4197-4203
[6]   MALONDIALDEHYDE AND THIOBARBITURIC ACID-REACTIVITY AS DIAGNOSTIC INDEXES OF LIPID-PEROXIDATION AND PEROXIDATIVE TISSUE-INJURY [J].
JANERO, DR .
FREE RADICAL BIOLOGY AND MEDICINE, 1990, 9 (06) :515-540
[7]  
JANIS RA, 1987, NISOLDIPINE 1987, P27
[8]   MYOCARDIAL AGING - ANTIOXIDANT ENZYME-SYSTEMS AND RELATED BIOCHEMICAL-PROPERTIES [J].
JI, LL ;
DILLON, D ;
WU, E .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (02) :R386-R392
[9]   REDUCTION OF CALCIUM-CHANNEL ANTAGONIST BINDING-SITES BY OXYGEN FREE-RADICALS IN RAT-HEART [J].
KANEKO, M ;
LEE, SL ;
WOLF, CM ;
DHALLA, NS .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1989, 21 (09) :935-943
[10]   DO ANTIOXIDANTS AND POLYUNSATURATED FATTY-ACIDS HAVE A COMBINED ASSOCIATION WITH CORONARY ATHEROSCLEROSIS [J].
KOK, FJ ;
VANPOPPEL, G ;
MELSE, J ;
VERHEUL, E ;
SCHOUTEN, EG ;
KRUYSSEN, DHCM ;
HOFMAN, A .
ATHEROSCLEROSIS, 1991, 86 (01) :85-90